ADVERTISEMENT

COVID-19: cancer patients at greater risk of breakthrough infection, severe outcomes

Miriam Davis, PhD   |   Clinical Summary   |   06 January 2023
ADVERTISEMENT

Booster doses are essential, especially with haematological cancer or any cancer undergoing treatment.

 

Takeaway

  • A population-based cohort of nearly 1.5 million people finds that cancer patients who have received 2 COVID-19 vaccinations are at greater risk for breakthrough SARS-CoV-2 infection and severe outcomes than matched noncancer controls.
  • Patients with...

          

Topic Challenges

left
right